Jose L Flores-Guerrero1, Maryse C J Osté1, Paula B Baraldi1, Margery A Connelly2, Erwin Garcia2, Gerjan Navis1, Stephan J L Bakker1, Robin P F Dullaart3. 1. Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. 2. Laboratory Corporation of America Holdings (LabCorp), Morrisville, NC 27560, USA. 3. Department of Internal Medicine, Division of Endocrinology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Abstract
BACKGROUND: Due to the critical shortage of kidneys for transplantation, the identification of modifiable factors related to graft failure is highly desirable. The role of trimethylamine-N-oxide (TMAO) in graft failure remains undetermined. Here, we investigated the clinical utility of TMAO and its dietary determinants for graft failure prediction in renal transplant recipients (RTRs). METHODS: We included 448 RTRs who participated in the TransplantLines Cohort Study. Cox proportional-hazards regression analyses were performed to study the association of plasma TMAO with graft failure. Net Benefit, which is a decision analysis method, was performed to evaluate the clinical utility of TMAO and dietary information in the prediction of graft failure. RESULTS: Among RTRs (age 52.7 ± 13.1 years; 53% males), the baseline median TMAO was 5.6 (3.0-10.2) µmol/L. In multivariable regression analysis, the most important dietary determinants of TMAO were egg intake (Std. β = 0.09 [95%CI, 0.01; 0.18]; p = 0.03), fiber intake (Std. β = -0.14 [95%CI, -0.22, -0.05]; p = 0.002), and fish and seafood intake (Std. β = 0.12 [95%CI, 0.03,0.21]; p = 0.01). After a median follow-up of 5.3 (4.5-6.0) years, graft failure was observed in 58 subjects. TMAO was associated with an increased risk of graft failure, independent of age, sex, the body mass index (BMI), blood pressure, lipids, albuminuria, and the Estimated Glomerular Filtration Rate (eGFR) (Hazard Ratio per 1-SD increase of TMAO, 1.62 (95% confidence interval (CI): 1.22; 2.14, p < 0.001)). A TMAO and dietary enhanced prediction model offered approximately double the Net Benefit compared to a previously reported, validated prediction model for future graft failure, allowing the detection of 21 RTRs per 100 RTRs tested, with no false positives versus 10 RTRs, respectively. CONCLUSIONS: A predictive model for graft failure, enriched with TMAO and its dietary determinants, yielded a higher Net Benefit compared with an already validated model. This study suggests that TMAO and its dietary determinants are associated with an increased risk of graft failure and that it is clinically meaningful.
BACKGROUND: Due to the critical shortage of kidneys for transplantation, the identification of modifiable factors related to graft failure is highly desirable. The role of trimethylamine-N-oxide (TMAO) in graft failure remains undetermined. Here, we investigated the clinical utility of TMAO and its dietary determinants for graft failure prediction in renal transplant recipients (RTRs). METHODS: We included 448 RTRs who participated in the TransplantLines Cohort Study. Cox proportional-hazards regression analyses were performed to study the association of plasma TMAO with graft failure. Net Benefit, which is a decision analysis method, was performed to evaluate the clinical utility of TMAO and dietary information in the prediction of graft failure. RESULTS: Among RTRs (age 52.7 ± 13.1 years; 53% males), the baseline median TMAO was 5.6 (3.0-10.2) µmol/L. In multivariable regression analysis, the most important dietary determinants of TMAO were egg intake (Std. β = 0.09 [95%CI, 0.01; 0.18]; p = 0.03), fiber intake (Std. β = -0.14 [95%CI, -0.22, -0.05]; p = 0.002), and fish and seafood intake (Std. β = 0.12 [95%CI, 0.03,0.21]; p = 0.01). After a median follow-up of 5.3 (4.5-6.0) years, graft failure was observed in 58 subjects. TMAO was associated with an increased risk of graft failure, independent of age, sex, the body mass index (BMI), blood pressure, lipids, albuminuria, and the Estimated Glomerular Filtration Rate (eGFR) (Hazard Ratio per 1-SD increase of TMAO, 1.62 (95% confidence interval (CI): 1.22; 2.14, p < 0.001)). A TMAO and dietary enhanced prediction model offered approximately double the Net Benefit compared to a previously reported, validated prediction model for future graft failure, allowing the detection of 21 RTRs per 100 RTRs tested, with no false positives versus 10 RTRs, respectively. CONCLUSIONS: A predictive model for graft failure, enriched with TMAO and its dietary determinants, yielded a higher Net Benefit compared with an already validated model. This study suggests that TMAO and its dietary determinants are associated with an increased risk of graft failure and that it is clinically meaningful.
Entities:
Keywords:
diet; kidney transplantation; net benefit; trimethylamine-N-oxide (TMAO)
Authors: Else van den Berg; Mariëlle F Engberink; Elizabeth J Brink; Marleen A van Baak; Michel M Joosten; Reinold O B Gans; Gerjan Navis; Stephan J L Bakker Journal: Clin J Am Soc Nephrol Date: 2012-08-30 Impact factor: 8.237
Authors: Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu Journal: J Am Soc Nephrol Date: 2015-07-30 Impact factor: 10.121
Authors: Huiling Wu; Julian Singer; Tony K Kwan; Yik Wen Loh; Chuanmin Wang; Jian Tan; Yan J Li; Sum Wing Christina Lai; Laurence Macia; Stephen I Alexander; Steven J Chadban Journal: J Am Soc Nephrol Date: 2020-06-01 Impact factor: 10.121
Authors: Zeneng Wang; Nathalie Bergeron; Bruce S Levison; Xinmin S Li; Sally Chiu; Xun Jia; Robert A Koeth; Lin Li; Yuping Wu; W H Wilson Tang; Ronald M Krauss; Stanley L Hazen Journal: Eur Heart J Date: 2019-02-14 Impact factor: 35.855
Authors: Eke G Gruppen; Erwin Garcia; Margery A Connelly; Elias J Jeyarajah; James D Otvos; Stephan J L Bakker; Robin P F Dullaart Journal: Sci Rep Date: 2017-10-23 Impact factor: 4.379
Authors: Mohammad A Almesned; Femke M Prins; Erik Lipšic; Margery A Connelly; Erwin Garcia; Robin P F Dullaart; Hilde E Groot; Pim van der Harst Journal: J Clin Med Date: 2021-12-01 Impact factor: 4.241